Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.240
-0.100 (-7.46%)
At close: Apr 17, 2026, 4:00 PM EDT
1.280
+0.040 (3.19%)
After-hours: Apr 17, 2026, 7:31 PM EDT

Tiziana Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2017FY 2016
Period Ending
Apr '26 Dec '24 Dec '23 Dec '22 Dec '17 Dec '16
158161112--
Market Cap Growth
30.70%35.49%-6.67%---
Enterprise Value
151.1111.810.3812.2700
Last Close Price
1.240.700.560.60--
PE Ratio
--1.27-0.66-0.80--
PB Ratio
16.023.942.07---
P/TBV Ratio
3.063.772.07---
P/FCF Ratio
--10.05-0.73-0.63--
P/OCF Ratio
--10.17-0.73-0.63--
EV/EBITDA Ratio
--0.75-0.58-0.84--
EV/EBIT Ratio
--0.75-0.58-0.84--
EV/FCF Ratio
--7.63-0.66-0.63--
Debt / Equity Ratio
-00.02---
Debt / EBITDA Ratio
-0.01-0.01-0.01---
Debt / FCF Ratio
-0.01-0.07-0.02---
Net Debt / Equity Ratio
-0.78-0.92-0.17---
Net Debt / EBITDA Ratio
0.390.230.05---
Net Debt / FCF Ratio
0.822.340.06---
Quick Ratio
1.651.001.09---
Current Ratio
1.721.021.12---
Return on Equity (ROE)
-242.92%-456.69%-606.68%---
Return on Assets (ROA)
-146.84%-173.85%-287.52%---
Return on Invested Capital (ROIC)
-1638.31%-825.22%-759.24%---
Return on Capital Employed (ROCE)
-281.26%-329.69%-637.17%---
Earnings Yield
-8.11%-79.00%-151.79%-125.00%--
FCF Yield
-5.54%-9.95%-137.05%-159.83%--
Buyback Yield / Dilution
-10.35%-4.10%-0.93%---
Total Shareholder Return
-10.35%-4.10%-0.93%---
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q